KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Asset Writedowns and Impairment (2020 - 2025)

Boston Scientific's Asset Writedowns and Impairment history spans 7 years, with the latest figure at -$27.0 million for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 164.29% to -$27.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$204.0 million, a 12.82% increase, with the full-year FY2025 number at $46.0 million, down 36.11% from a year prior.
  • Asset Writedowns and Impairment hit -$27.0 million in Q4 2025 for Boston Scientific, down from $27.0 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for BSX hit a ceiling of $197.0 million in Q4 2021 and a floor of -$246.0 million in Q3 2024.
  • Historically, Asset Writedowns and Impairment has averaged $26.1 million across 5 years, with a median of $34.5 million in 2024.
  • The widest YoY moves for Asset Writedowns and Impairment: up 235.48% in 2024, down 24700.0% in 2024.
  • Tracing BSX's Asset Writedowns and Impairment over 5 years: stood at $197.0 million in 2021, then tumbled by 36.55% to $125.0 million in 2022, then plummeted by 124.8% to -$31.0 million in 2023, then surged by 235.48% to $42.0 million in 2024, then tumbled by 164.29% to -$27.0 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for BSX at -$27.0 million in Q4 2025, $27.0 million in Q3 2025, and $42.0 million in Q4 2024.